Anxiety disorders are illnesses that cause people to experience exaggerated fright and apprehension in response to external or internal stimuli. These conditions are often related to the biological and psychological makeup of the individual and may be familial in nature. If untreated, these illnesses can significantly reduce productivity and impair a person’s ability to function in daily life. Anxiety disorders affect approximately 24 million American adults (Narrow WE et al 2002). Nearly 15 percent of adults will experience an anxiety disorder in their lifetime (Bourden KH et al 1992; Schatzberg AF 1991).
Anxiety can occur independently or in conjunction with other psychiatric or medical conditions, such as depression, phobias, chronic fatigue, cardiac disease, or respiratory compromise. Moreover, chronic anxiety is associated with a higher risk of morbidity and mortality from cerebrovascular and cardiovascular diseases, such as hypertension, cardiac ischemia, and arrhythmias, and it predisposes people to a range of other disorders (Muller JE et al 2005; Weissman MM et al 1990; Coryell W 1986, 1988). People with severe anxiety disorders who experience adverse life events such as divorce or financial disaster may be at increased risk of suicidal behavior (Allgulander C et al 1991).
Typically, anxiety disorders are treated with an array of psychoactive medications that alter or increase levels of neurotransmitters. Unfortunately, these medications also carry sometimes significant side effects, including the risk of dependency. A number of nutrients have been identified that act along pathways similar to those of prescription medications or have a general antianxiety effect. In addition, Life Extension has uncovered exciting new research that may alter the way medical science one day looks at anxiety disorders. Elevated homocysteine, which has been implicated in heart disease and depression, may also play a role in anxiety disorders. Also, abnormal hormone levels may exacerbate anxiety disorders. On the basis of the newest research, Life Extension believes that people suffering from anxiety disorders should test for elevated homocysteine and abnormal hormone levels and correct these if necessary.
Generalized anxiety disorder. Generalized anxiety disorder affects about 4 million adult Americans and is characterized by chronic, excessive worry and tension (Narrow WE et al 2002; Wittchen HU 2002; Wittchen HU et al 1994). Other symptoms may include restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbances. A diagnosis of generalized anxiety disorder is confirmed when an individual experiences excessive worrying about everyday problems and three or more of the above symptoms more days than not for at least six consecutive months (American Psychiatric Association 2000).
Panic disorder. Panic disorder is characterized by repeated episodes of intense fear that appear often without warning and with varying frequency. Panic disorder afflicts about 2.8 million Americans, and its prevalence appears to have been increasing since 1980 (Goodwin RD 2003; Narrow WE et al 2002). Symptoms may include palpitations, accelerated heart rate, sweating, trembling, shortness of breath, feeling of choking, chest pain, nausea or abdominal distress, dizziness, feelings of unreality, fear of losing control or dying, and chills or hot flashes. A panic disorder is diagnosed when a person experiences recurrent, unexpected panic attacks and at least one of the attacks has been followed by one or more of the following: persistent concern about future attacks, worry about the implications of the attack, and a significant change in behavior related to the attacks (American Psychiatric Association 2000).
Obsessive-compulsive disorder. Obsessive-compulsive disorder (OCD) is characterized by recurrent and persistent thoughts and/or impulses and repetitive ritualistic activities and behavior. These rituals provide only temporary relief from anxiety (Jenike MA 2004). OCD affects approximately 4.3 million American adults and 2 to 3 percent of the world’s population (Jenike MA 2004; Narrow WE et al 2002). Individuals with OCD may have unwanted thoughts or images or an urgent need to perform certain rituals (e.g., touch, check, or count things repeatedly).
Phobia. Phobias are seemingly inexplicable fears. Social phobias (social anxiety disorders) are characterized by excessive self-consciousness, with an intense fear of humiliation or embarrassment, and feelings of being watched and judged by others while in public situations. These feelings sometimes begin weeks in advance of an event. Social phobias affect about 6.5 million Americans (Narrow WE et al 2002). Physical symptoms of social phobias include blushing, sweating, trembling, nausea, and difficulty speaking. The diagnosis of social phobias is made when people experience a marked and persistent fear of one or more social or performance situations they are exposed to, avoid, or have symptoms of anxiety toward (American Psychiatric Association 2000).
Posttraumatic stress disorder. Posttraumatic stress disorder (PTSD) is precipitated by experiencing or witnessing a traumatic or terrifying life event, such as a serious accident, a violent crime, or a natural disaster. People with PTSD may relive the event in nightmares or have disturbing recollections of it during waking hours. Ordinary events can trigger flashbacks that may result in a loss of reality, causing the person to believe the event is happening again. Approximately 5.2 million Americans are affected by PTSD, which can occur at any age (Narrow WE et al 2002; Margolin G et al 2000).
Symptoms associated with PTSD include inability to sleep, hypersensitivity to external stimuli, feelings of detachment or numbness, and loss of memory of the time surrounding the traumatic experience. In addition to the presence of these symptoms, doctors considering a diagnosis of PTSD consider whether a patient persistently reexperiences the traumatic event, such as by recollecting it, dreaming about it, experiencing hallucinations or flashbacks, or physically reacting to internal or external cues that symbolize or resemble an aspect of it. For a diagnosis of PTSD, symptoms must be present for more than one month but may occur years after the traumatic event (American Psychiatric Association 2000).
Various studies have conclusively linked decreased folate and elevated homocysteine to depressive disorders. However, little is known about the connection between elevated homocysteine and anxiety disorders. In recent years, a number of research teams around the world have conducted preliminary studies examining the possible role of elevated homocysteine in anxiety. The results have been intriguing.
In one study, for instance, 23 patients with OCD were evaluated for folate and homocysteine levels, and their levels were compared with those of healthy control participants. Researchers found that folate levels were significantly lower in OCD patients than in controls and homocysteine levels were higher. Furthermore, the more severe the OCD, the more severe the folate deficiency (Atmaca M et al 2005). While this study may shed some light on a possible underlying cause of anxiety disorders, the research needs to be duplicated by additional research groups. However, Life Extension recommends that people strive for a homocysteine level of less than 8.00 mmol/L, which has been shown to protect against heart disease. In light of this research, it may be prudent for people with anxiety disorders to also measure and supplement with folic acid and B vitamins to lower homocysteine, especially if they are also depressed.
No single laboratory test can diagnose anxiety; instead, medical professionals rely on clinical judgment to make the diagnosis. There are also several screening tests available to help determine the cause, type, and severity of anxiety (Rush AJ Jr et al 2000). Once an anxiety disorder has been diagnosed, treatment will often integrate several approaches, including diet and lifestyle changes, relaxation and massage therapy, psychotherapy (behavioral therapy or cognitive-behavioral therapy), supplementation, and drug intervention.
Cognitive-behavioral therapy involves the modification of thinking patterns that control the thoughts and sensations accompanying anxiety and fear. It helps individuals recognize cognitive distortions, or ways in which they perceive the world that are not accurate. Patients are then shown how these distortions produce reactions such an anxiety and panic, and they are offered special tools to detect when their thinking is distorted and methods to replace distorted thoughts with more accurate ones. Cognitive-behavioral therapy is an effective first-line treatment for anxiety disorders (Otto MW et al 2004). Cognitive-behavioral therapy has been shown to be effective in treating all the anxiety disorders (Rouillon F 2004; Harvey AG et al 2003; Tonks A 2003; Heimberg RG 2002; March JS et al 2001; Goldberg C 1998; Barlow DH 1997; Wakefield M et al 1997).
Behavior therapy uses several techniques, such as diaphragmatic breathing and exposure therapy. Diaphragmatic breathing teaches people how to control the physical signs of anxiety by taking slow, deep breaths, which helps control hyperventilation. Exposure therapy relies on small and progressive exposures to whatever frightens them. The gradual, safe exposures help anxiety sufferers build confidence and control their anxiety.
Drug therapy is often used in combination with psychotherapy to manage the biochemical and physiological abnormalities that produce anxiety, including alternations in the levels of serotonin, norepinephrine, and cortisol (the stress hormone). The following types of drugs are frequently prescribed to treat anxiety disorders:
In general, people are advised to eat a healthful diet with high quantities of organic fresh fruits and vegetables and plenty of water and to avoid foods that are high in saturated fats and refined carbohydrates. In addition, the following nutrients may support healthy levels of neurotransmitters or relieve anxiety:
Amino acids. Amino acids, particularly neurotransmitter precursors, are essential to normal brain function. The ability of L-tryptophan and L-tyrosine to produce serotonin and norepinephrine varies directly with plasma concentrations of L-tryptophan and L-tyrosine and inversely with plasma concentrations of other large neutral amino acids (Fernstrom J 2000).
Depletion of serotonin and its precursor L-tryptophan increases symptoms of anxiety, particularly panic disorder (Bell C et al 2001). In experimental settings, diets deficient in the amino acids L-tryptophan, L-phenylalanine, and L-tyrosine can rapidly decrease serotonin, causing anxiety symptoms (Leyton M et al 2003).
Melatonin. Melatonin, a hormone made from serotonin, has neuroprotective and antioxidant properties, detoxifies free radicals, and stimulates antioxidative enzymes (Gupta YK et al 2003). Some research has shown that people with panic disorders have abnormal melatonin patterns (Nathan PJ et al 1998). Taken at night, melatonin can help people obtain refreshing sleep.
Theanine. Theanine is an amino acid found in green tea and produces a calming effect on the brain (Yokogoshi H et al 1998). It easily crosses the blood-brain barrier and produces subtle changes in biochemistry, including increased production of GABA and dopamine, which cause a tranquilizing effect. Research suggests theanine has neuroprotective effects in the brain, particularly in preventing neuronal death in the hippocampus (Kakuda T 2002). In one human study, healthy volunteers were given theanine and a benzodiazepine and subjected to an experimentally induced anticipatory anxiety condition. While neither the prescription drug nor theanine helped with the acute symptoms of anxiety, theanine appeared to outperform the benzodiazepine in the baseline measurement of anxiety (Lu K et al 2004). Theanine is also a caffeine antagonist, offsetting the stimulant properties of caffeine without causing drowsiness (in rats) (Kakuda T et al 2000).
Adapton. Adapton is a naturally occurring substance containing garum armoricum, an extract of garum, a deep sea fish. Adapton consists of unique polypeptides that act as precursors to endorphins and other neurotransmitters that exert a regulatory effect on the nervous system; it also contains an omega-3 fatty acid. There appear to be no major side effects other than minor heartburn, diarrhea, and nervous irritation.
Omega-3 fatty acids. The omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are necessary for proper brain function. In the typical Western diet, people often suffer from an increased ratio of inflammatory omega-6 fatty acids to anti-inflammatory omega-3 fatty acids. It has been established that this imbalance can lead to a number of negative health problems. Fortunately, the imbalance can be addressed easily by supplementing with EPA and DHA, which have been shown to have mood stabilizing effects and possibly other neuropsychiatric effects. In one multipart study that relied on both human student volunteers and animals, DHA was shown to reduce aggression and anxiety in both stressful and nonstressful settings (Hamazaki T et al 1999). Another human study showed that a mixture of omega-3 and omega-6 fatty acids can reduce test-taking anxiety among students (Yehuda S et al 2005).
Herbs and botanical medicine. Botanical herbs have properties to manage many psychiatric disorders, including anxiety (Cagnacci A et al 2003; Edzard E 2002; Fugh-Berman A et al 1999). Herbal products can vary greatly in their composition, depending on variation in the raw plant material caused by genetic factors, climate, growing season, soil, rainfall, growing methods, and extraction processes. For this reason product preparation, quality, efficacy, and safety can differ widely among manufacturers. The following herbs have antianxiety effects or target key molecular sites associated with neurotransmitters in the central nervous system:
By now, it is well known that most steroid hormones (e.g., pregnenolone, estrogen, progesterone, testosterone, and DHEA) are neurologically active. In fact, large quantities of DHEA, as well as estrogen and progesterone receptors, are found in the brain. These hormones have a number of effects within the brain, including regulation of mood. Accordingly, a number of studies have linked abnormalities in hormone levels to various anxiety disorders (Birzniece V et al 2006; Cohen H et al 2006; Strous RD et al 2006). In addition, studies have documented that abnormalities in the hypothalamic-pituitary-adrenal axis, which controls the body’s response to stress through the release of cortisol and DHEA, can predispose a person to anxiety and depression (Leonard BE 2005). During times of stress and anxiety, the balance between cortisol and DHEA is altered in favor of cortisol.
In particular, progesterone seems to have a potent antianxiety effect. For instance, in an animal study that compared normal mice to animals that had been bred to have their progestin receptor knocked out, researchers found that progesterone decreased anxiety behavior through a mechanism of action similar to that of benzodiazepines, by acting on GABA receptors (Frye CA et al 2006). Another study found that a single dose of progesterone given to animals decreased anxiety indicators during stress tests, while the abrupt cessation of progesterone therapy increased measures of anxiety (Saavedra M et al 2006).
It’s important to note that all the major sex hormones are related to one another. These hormones are synthesized in a cascade from cholesterol, and alterations in the level of one sex hormone may affect hormones throughout the cascade. Thus, people with anxiety may benefit from comprehensive hormone testing and, if necessary, a program of bioidentical hormone replacement. Life Extension recommends that you strive to achieve the hormone levels of healthy people in their late 20s.